| pubmed-article:20035068 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C2004454 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C2349984 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C0015219 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C1707418 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C1292430 | lld:lifeskim |
| pubmed-article:20035068 | lifeskim:mentions | umls-concept:C0332162 | lld:lifeskim |
| pubmed-article:20035068 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:20035068 | pubmed:dateCreated | 2010-1-26 | lld:pubmed |
| pubmed-article:20035068 | pubmed:abstractText | It has recently been proposed that fluid-attenuated inversion recovery (FLAIR) imaging may serve as a surrogate marker for time of symptom onset after stroke. We assessed the hypothesis that FLAIR imaging could be used to decide if an MRI was performed within 4.5 hours from symptom onset or later. | lld:pubmed |
| pubmed-article:20035068 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20035068 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20035068 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20035068 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20035068 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20035068 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20035068 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:20035068 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:20035068 | pubmed:author | pubmed-author:EndresMatthia... | lld:pubmed |
| pubmed-article:20035068 | pubmed:author | pubmed-author:FiebachJochen... | lld:pubmed |
| pubmed-article:20035068 | pubmed:author | pubmed-author:BruneckerPete... | lld:pubmed |
| pubmed-article:20035068 | pubmed:author | pubmed-author:EbingerMartin... | lld:pubmed |
| pubmed-article:20035068 | pubmed:author | pubmed-author:RozanskiMicha... | lld:pubmed |
| pubmed-article:20035068 | pubmed:author | pubmed-author:GalinovicIvan... | lld:pubmed |
| pubmed-article:20035068 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20035068 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:20035068 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20035068 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20035068 | pubmed:pagination | 250-5 | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:meshHeading | pubmed-meshheading:20035068... | lld:pubmed |
| pubmed-article:20035068 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20035068 | pubmed:articleTitle | Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock? | lld:pubmed |
| pubmed-article:20035068 | pubmed:affiliation | Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany. martin.ebinger@charite.de | lld:pubmed |
| pubmed-article:20035068 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20035068 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20035068 | lld:pubmed |
